22824-34-6

Basic information

• Product Name: 1,1,7-trimethyl-1,2,3,4-tetrahydronaphthalene
• CAS NO: 22824-34-6
• Molecular Formula: C₁₃H₁₈
• Molecular Weight: 174.282
• Mol File: 22824-34-6.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 238.1°C at 760 mmHg
• Flash Point: 94.6°C
• Density: 0.912g/cm³
• Vapor Pressure: 0.0665mmHg at 25°C
• Refractive Index: 1.51
• CAS DataBase Reference: 1,1,7-trimethyl-1,2,3,4-tetrahydronaphthalene(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1,7-trimethyl-1,2,3,4-tetrahydronaphthalene(22824-34-6)
• EPA Substance Registry System: 1,1,7-trimethyl-1,2,3,4-tetrahydronaphthalene(22824-34-6)

Safety Data

• Hazardous Substances Data: 22824-34-6(Hazardous Substances Data)

Usage

Physical state

Colorless liquid

Odor

Strong, sweet

Usage

Fragrance ingredient in perfumes and personal care products

Usage

Solvent in industrial applications

Family

Tetrahydronaphthalene family

Classification

Aromatic hydrocarbon

Production method

Catalytic hydrogenation of naphthalene

Flammability

Known to be flammable

Health hazard

May cause irritation to skin and eyes upon contact

Upstream product

• 73177-66-9 4-methyl-1-(4-methylphenyl)-1-pentanol 
• 22184-00-5 2-(methyl-5-(4-methylphenyl))-2-pentanol 
• 4548-78-1 (3-methylbutyl)magnesium bromide 
• 104-87-0 4-methyl-benzaldehyde 
• 4619-20-9 3-(4-methylbenzoyl)propionic acid 
• 24306-23-8 methyl 4-(4-methylphenyl)butanoate 
• 108-88-3 toluene 
• 4521-22-6 4-(4-methylphenyl)butyric acid 
• 51082-27-0 1-methyl-4-(4-methylpent-3-en-1-yl)benzene 

Downstream Products

• 169124-30-5 methyl 4-<(3,5,5-trimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl>benzoate 
• 169124-31-6 methyl 4-<(3,5,5-trimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl>benzoate 
• 98453-65-7 C₂₀H₂₂N₂O₂S 

Relevant articles and documents

BEXAROTENE DERIVATIVES AND THEIR USE IN TREATING CANCER

This disclosure relates to compositions and methods for treating cancer. Specifically, this disclosure relates to bexarotene derivatives, methods for treating cancer, autoimmune disorders, and/or skin dermatitis, and/or methods for increasing peripheral blood counts and/or improving immune system function.

Compositions and methods for treatment of hyperproliferative diseases

The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention also relates to methods of treating hyperproliferative diseases by administering a retinoid X receptor agonis

Retinoic acid receptor antagonists as promoters of angiogenesis

Methods and compositions for treating various disorders by administering a therapeutically effective amount of a retinoic acid receptor antagonist alone or in combination or in conjunction with other therapeutic agents to promote angiogenesis are provided